Infinity Pharmaceuticals, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 23 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-05-19: Reporting owner Hamermesh Joshua; Form 3; Security Stock Option (Right to Buy); Transaction Holding.
- 2011-05-18: Reporting owner EVNIN ANTHONY B; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-05-18: Reporting owner EVNIN ANTHONY B; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-05-18: Reporting owner Holtzman Steven H; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-05-19 holding as of filing | Hamermesh Joshua Officer (VP, Business & Corporate Dev) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $5.62 exercise price | 2011-05-19 | ||
| 2011-05-18 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $6.80 exercise price | 2011-05-20 | |
| 2011-05-18 | EVNIN ANTHONY B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $6.80 exercise price | 2011-05-20 | |
| 2011-05-18 | Holtzman Steven H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | Holtzman Steven H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,000 12,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | LANDER ERIC S Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | Babler Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | Babler Martin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,000 2,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | Lee Patrick Pak-Tin Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | LEVINE ARNOLD J Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | SMITH IAN F Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,000 4,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | Lynch Thomas J. Jr. Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | VENUTI MICHAEL C Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,000 4,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-05-18 | TANANBAUM JAMES B Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,000 6,000 owned after | $6.80 exercise price | 2011-05-19 | |
| 2011-01-06 | ADAMS JULIAN Officer (President of R&D) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +106,210 106,210 owned after | $5.94 exercise price | 2011-01-07 | |
| 2011-01-06 | Holtzman Steven H Director | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +120,000 120,000 owned after | $5.94 exercise price | 2011-01-07 | |
| 2011-01-06 | Tucker Winselow S. Jr. Officer (Vice President, Marketing) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +6,552 6,552 owned after | $5.94 exercise price | 2011-01-07 | |
| 2011-01-06 | Quirk Gerald E Officer (VP,Cor. Affairs & Gnrl Counsel) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,828 9,828 owned after | $5.94 exercise price | 2011-01-07 | |
| 2011-01-06 | Perkins Adelene Q Director, Officer (Pres & Chief Executive Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +160,550 160,550 owned after | $5.94 exercise price | 2011-01-07 | |
| 2011-01-06 | Palombella Vito J. Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +39,520 39,520 owned after | $5.94 exercise price | 2011-01-07 | |
| 2011-01-06 | Lindblom Christopher M Officer (Controller & Asst. Treasurer) | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,828 9,828 owned after | $5.94 exercise price | 2011-01-07 |